FDA 510(k)

MODIFICATION TO SANARUS CENTRICA CORE TISSUE BIOPSY

K-Number: K022879 · 2002-09-23

Decision Date2002-09-23

Product CodeKNW

Advisory CommitteeGU

DecisionSubstantially Equivalent

Device Summary

MODIFICATION TO SANARUS CENTRICA CORE TISSUE BIOPSY is the device name listed in this FDA 510(k) record. The listed applicant is Sanarus Medical, Inc.. It received FDA 510(k) clearance on 2002-09-23 under 510(k) number K022879. The device is classified under product code KNW. It was reviewed by the GU advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the MODIFICATION TO SANARUS CENTRICA CORE TISSUE BIOPSY?

MODIFICATION TO SANARUS CENTRICA CORE TISSUE BIOPSY is a medical device that received FDA 510(k) clearance on 2002-09-23. The listed applicant is Sanarus Medical, Inc.. The 510(k) number is K022879.

When did MODIFICATION TO SANARUS CENTRICA CORE TISSUE BIOPSY receive FDA 510(k) clearance?

MODIFICATION TO SANARUS CENTRICA CORE TISSUE BIOPSY received FDA 510(k) clearance on 2002-09-23, under 510(k) number K022879.

Who is the listed applicant for MODIFICATION TO SANARUS CENTRICA CORE TISSUE BIOPSY?

The FDA 510(k) record lists Sanarus Medical, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for MODIFICATION TO SANARUS CENTRICA CORE TISSUE BIOPSY?

The FDA product code for MODIFICATION TO SANARUS CENTRICA CORE TISSUE BIOPSY is KNW.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITING NCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITING NCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDED NCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Sanarus Medical, Inc. as applicant

K080171SANARUS INCORE ROTATIONAL CORE BIOPSY DEVICE, MODELS CB3010, CB3012 K073533SANARUS V2 TREATMENT SYSTEM K062896V2 TREATMENT SYSTEM (V2 CONSOLE, V2 ICE PROBE, V2 DEWARS) MODELS; VS3000, VP0600, VD0600 K061510SANARUS VISICA TREATMENT SYSTEM K052861MODIFICATION TO:SANARUS VISICA TREATMENT SYSTEM , MODELS VS2000 K051581SANARUS CASSI II ROTATIONAL CORE BIOPSY SYSTEM, MODEL CS2000

View all 14 devices →

Related Devices (Code: KNW)

K260517Automatic Core Biopsy InstrumentZhejiang Curaway Medical Technology Co., Ltd.K262571EnCor EnCompass™ Breast Biopsy and Tissue Removal SystemBard Peripheral Vascular, Inc.K262792Brevera Biopsy System with CorLumina Imaging Technology (BREVDISP09)Hologic, Inc.K260572Marrow MarxmanMedimetrix, LLC K261196Promisemed VeriEcto Automatic Biopsy NeedlesPromisemed Hangzhou Meditech Co., Ltd.K260365Mammotome Prima™ MR Dual Vacuum-Assisted Breast Biopsy System Control Module; Mammotome Prima™ MR Dual Vacuum-Assisted Breast Biopsy System Disposable Probe, 8 gauge; Mammotome Prima™ MR Dual Vacuum-Assisted Breast Biopsy System Disposable Targeting Set, 8 gauge; Mammotome Prima™ MR Dual Vacuum-Assisted Breast Biopsy System Foot Switch; Mammotome Prima™ MR Dual Vacuum-Assisted Breast Biopsy System Reusable Tray; Mammotome Prima™ MR Dual Vacuum-Assisted Breast Biopsy System Battery CharDevicor Medical Products, Inc.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.